EKOS™ Endovascular System

EKOS™ Ultrasound Guided Catheter directed thrombolysis for deep vein thrombosis and pulmonary embolism.
EKOS™ The targeted ultrasound waves differentiate this technology, providing accelerated clot dissolution by unwinding the fibrin matrix.
play icon
See how the EKOS™ device mechanism of action works.
The EKOS™ catheter is comprised of two parts: the Infusion catheter and the ultrasonic core.
EKOS™ Ultrasound Guided Catheter directed thrombolysis for deep vein thrombosis and pulmonary embolism.
EKOS™ The targeted ultrasound waves differentiate this technology, providing accelerated clot dissolution by unwinding the fibrin matrix.
play icon
See how the EKOS™ device mechanism of action works.
The EKOS™ catheter is comprised of two parts: the Infusion catheter and the ultrasonic core.
EKOS™ Ultrasound Guided Catheter directed thrombolysis for deep vein thrombosis and pulmonary embolism.
EKOS™ The targeted ultrasound waves differentiate this technology, providing accelerated clot dissolution by unwinding the fibrin matrix.
See how the EKOS™ device mechanism of action works.
The EKOS™ catheter is comprised of two parts: the Infusion catheter and the ultrasonic core.

The EKOS™ Endovascular System is used for ultrasound-assisted, catheter-directed thrombolysis to quickly and safely dissolve pulmonary embolism (PE). Minimally invasive, EKOS™ leverages the power of targeted ultrasonic waves to thin and separate fibrin strands and accelerates lytic dispersion deeper into the clot.

EKOS™ was the first interventional device indicated for the treatment of pulmonary embolism. It is also used to treat deep vein thrombosis (DVT) and peripheral arterial occlusion (PAO).

Visit our Venous Thromboembolism portal

View EKOS™ Catheter in 3D >

View EKOS™ Console in 3D >

Product Description

The EKOS™ Endovascular System includes an ultrasonic core within an infusion catheter, and control unit. The ultrasonic core generates an acoustic field which greatly accelerates lytic dispersion by driving the drug deeper into the clot and unwinding the fibrin to expose plasminogen receptor sites. 

Acoustic Pulse Thrombolysis™

  • Speeds time-to-clot dissolution.
  • Results in quality clinical outcomes.
  • Increases clot removal and enhances clinical improvement compared to either standard catheter-directed drug therapy or thrombectomy.1,2
  • Requires significantly shorter treatment times compared to standard CDT.3

Targets the Thrombus Safely

  • Lowers the risk of bleeding and other complications.3,4
  • Dissolves clots without damaging vessels, valves or walls.3

More Effective Drug Delivery

  • Reduces dosage requirements by as much as 68% compared to standard, catheter-directed drug therapy.3
  • Requires up to 4x less drug dosage than traditional systemic delivery.5
  • Reduces RV/LV ratio with as little as 8mg total tPA used in combination with EKOS™ therapy.6

Superior Clot Clearance2,3

  • 48% greater drug absorption within 1 hour.1
  • 84% greater drug absorption within 2 hours. 1
Top